Exenatide
Also known as: Byetta · Bydureon · Exendin-4
The first GLP-1 agonist ever, discovered in Gila monster venom. Laid the groundwork for the entire modern incretin weight loss era.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~2.4 hours (Byetta) / ~2 weeks (Bydureon ER)
5–10 mcg twice daily or 2 mg weekly (ER)
Subcutaneous injection
Mechanism of Action
Exendin-4 derived GLP-1 mimetic that enhances insulin secretion, slows gastric emptying, and reduces glucagon in a glucose-dependent manner.
Key Research Areas
Frequently Asked Questions
What is Exenatide?▾
How does Exenatide work?▾
What is the recommended dosage for Exenatide?▾
What is the half-life of Exenatide?▾
Is Exenatide FDA approved?▾
Research Disclaimer
The information provided about Exenatide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.